Jr Fraser Cummings

17PUBLICATIONS
80CO-AUTHORS
Epidemiological methodsImmunogenetics (incl. genetic immunology)Rheumatology and arthritisApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Information systems development methodologies and practice
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Jul 10, 2026
Real-World Effectiveness, Safety and Quality of Life With Ustekinumab for the Treatment of Crohn's Disease: Results of the UK Ustekinumab Real World Evidence Study (UndieS) Study Group.

|Jun 04, 2026
The UK vedolizumab real-life experience study in inflammatory bowel disease (VEST): patient characteristics, drug persistence and patient-centred outcomes.

|Jan 23, 2026
Comparative analysis of inflammatory bowel disease (IBD) patient- and service-reported quality of care using 2019 and 2023 UK benchmarking data from more than 26 000 adult patient respondents and 154 IBD services.

A Barney Hawthorne, Paul Christiansen, Ian Arnott

|Jan 23, 2026
Research engagement and patient-reported quality of care: a cross-sectional study of UK inflammatory bowel disease services.

Robert J Mulligan, Pat Ryan, Lauren C Beck

|May 11, 2024
A randomised, crossover trial exploring the patient perspective and effectiveness of biosimilar adalimumab transition: IBD reference and biosimilar adalimumab cross over study (iBaSS).

David Young, Clare Harris, Sohail Rahmany

|Nov 13, 2023
Real-World Experience of Adalimumab Biosimilar (ABP 501) Use in Patients with Inflammatory Bowel Disease in Europe.

Ran Jin, Chidozie Nduka, Delphine Courmier

Pageof 3

Frequent Collaborators

5 joint publications

Christopher Andrew Lamb

3 joint publications

Tariq Ahmad

3 joint publications

Nicholas A Kennedy

3 joint publications

Keith Bodger